Business
Therma Bright Secures Exclusive License Agreement for AI4LYF's Patent-Pending Digital Cough Technology (DCT) to Detect Respiratory Diseases
Toronto, Ontario--(Newsfile Corp. - February 16, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: ...
About this update from Therma Bright Inc.
[{"type":"text","content":"Therma Bright Secures Exclusive License Agreement for AI4LYF's Patent-Pending Digital Cough Technology (DCT) to Detect Respiratory DiseasesToronto, Ontario--(Newsfile Corp. - February 16, 2023) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) (\"Therma Bright\" or the \"Company\"), developer of its smart-enabled AcuVid™ COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, is pleased to announce that it has finalized and signed the exclusive worldwide licensing rights to market and sell AI4LYF's Digital Cough Technology (DCT). DCT can accurately and almost instantaneously detect multiple respiratory diseases, including COVID-19, simply and efficiently through a smartphone app, anytime, anywhere. The exclusive license agreement also will allow Therma Bright to develop the DCT solution for other respiratory diseases, such as asthma, pneumonia, bronchiolitis, and chronic obstructive pulmonary disease.As announced in November 2022, AI4LYF's Digital Cough Test (DCT) is a groundbreaking patent-pending technology that is powered by an innovative AI engine. The DCT technology achieves this by digitally dissecting cough sounds into hundreds of features. Then AI4LYF's proprietary AI solution analyzes these \"cough features\" to detect the subtle and peculiar signatures of specific respiratory diseases. The DCT app will record the user's cough when prompted on the smart phone app. The app, powered by AI4LYF's AI-driven technology, then produces a positive or negative Covid test result within one minute, with an accuracy above 94%. AI4LYF's DCT cough analyzer results for COVID-19 are comparable to current PCR Covid testing methods. \"It's been a very productive few months working with Rob and his team on the licensing agreement for our innovative AI-driven cough detection solution for Covid-19 virus and other respiratory diseases,\" explained Ali Imran, Co-Founder and CEO of AI4LYF. \"AI4LYF's team is excited to work closely with the Therma Bright team on the regulatory submission for our DCT solution followed by marketplace deployment. In working with Therma Bright we look forward to bringing further solutions to detect and prevent the spread of other respiratory diseases.\"\"Therma Bright is excited to partner with AI4LYF to bring its Digital Cough Technology (DCT) to the marketplace,\...